BioSpace News Archive

New board appointment brings expertise in surgical robotics, data analytics and medical device commercialization

pringCM, a DocuSign company, today announced that it has launched a social media campaign to raise money for New Genes, a not-for-profit organization dedicated to gene replacement therapy to address terminal childhood diseases.

Thomas Rapisardo, M.D., today received the first annual Healthcare Hero Award from The Independence Fund for his exemplary service and dedication to America’s wounded, ill, and injured Veterans.

Sustainable Healthy Communities (SHC), a wholly owned subsidiary of the National Minority Quality Forum (NMQF), today announced a new population health initiative aimed at improving patient outcomes in underserved communities.

Phosphorus, a leader in diagnostic and bioinformatic solutions for clinical Next Generation Sequencing (NGS), announced today, at the National Lipid Association Fall Clinical Lipid Update meeting, the launch of an expanded genetic test for inherited dyslipidemias.

Two widely respected and prolific breast cancer investigators today join the ranks of an esteemed group of scientists as recipients of this year’s Brinker Awards – the highest scientific honor awarded by Susan G. Komen®, the world’s leading breast cancer organization.

Puration, Inc. (USOTC: PURA) (“PURA”) today announced executing a letter of intent (“LOI”) to spinoff its cannabis cultivation business. The prospective “spinoff” will be affected by selling the cannabis cultivation business to a target publicly traded holding company

Arena Pharmaceuticals, Inc. today announced that the Company will host an R&D Day to outline key catalysts and new information on the clinical programs for its potentially first- or best-in-class late-stage investigational compounds: etrasimod in inflammatory bowel disease (IBD), ralinepag in pulmonary arterial hypertension (PAH), and olorinab in visceral pain.

Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on Cancer and its side effects, today announced that Dr. Gil Bar-Sela is scheduled to present his findings at the 3rd International Medical Cannabis Conference

Los Altos High School Named Recipient of $20,000 Grant to Bolster Science Program